A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation

Meifang Li(Guangzhou University of Chinese Medicine), Yuhua Li(Zhujiang Hospital)
Journal of Experimental & Clinical Cancer Research
May 22, 2019
Cited by 15


Related Papers